These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32075688)

  • 21. Differences in clinical disease and immune response of pigs challenged with a high-dose versus low-dose inoculum of porcine reproductive and respiratory syndrome virus.
    Loving CL; Brockmeier SL; Vincent AL; Lager KM; Sacco RE
    Viral Immunol; 2008 Sep; 21(3):315-25. PubMed ID: 18788940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity.
    Martelli P; Gozio S; Ferrari L; Rosina S; De Angelis E; Quintavalla C; Bottarelli E; Borghetti P
    Vaccine; 2009 Jun; 27(28):3788-99. PubMed ID: 19442420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An interferon inducing porcine reproductive and respiratory syndrome virus vaccine candidate elicits protection against challenge with the heterologous virulent type 2 strain VR-2385 in pigs.
    Fontanella E; Ma Z; Zhang Y; de Castro AM; Shen H; Halbur PG; Opriessnig T
    Vaccine; 2017 Jan; 35(1):125-131. PubMed ID: 27876202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Porcine circovirus type 2 infection decreases the efficacy of a modified live porcine reproductive and respiratory syndrome virus vaccine.
    Opriessnig T; McKeown NE; Harmon KL; Meng XJ; Halbur PG
    Clin Vaccine Immunol; 2006 Aug; 13(8):923-9. PubMed ID: 16893993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic architecture of gene expression underlying variation in host response to porcine reproductive and respiratory syndrome virus infection.
    Kommadath A; Bao H; Choi I; Reecy JM; Koltes JE; Fritz-Waters E; Eisley CJ; Grant JR; Rowland RR; Tuggle CK; Dekkers JC; Lunney JK; Guan LL; Stothard P; Plastow GS
    Sci Rep; 2017 Apr; 7():46203. PubMed ID: 28393889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Type I interferon suppression-negative and host mRNA nuclear retention-negative mutation in nsp1β confers attenuation of porcine reproductive and respiratory syndrome virus in pigs.
    Ke H; Han M; Zhang Q; Rowland R; Kerrigan M; Yoo D
    Virology; 2018 Apr; 517():177-187. PubMed ID: 29402432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Porcine reproductive and respiratory syndrome virus persistence in blood, spleen, lymph nodes, and tonsils of experimentally infected pigs depends on the level of CD8high T cells.
    Lamontagne L; Pagé C; Larochelle R; Magar R
    Viral Immunol; 2003; 16(3):395-406. PubMed ID: 14583153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenovirus-mediated expression of interferon-alpha delays viral replication and reduces disease signs in swine challenged with porcine reproductive and respiratory syndrome virus.
    Brockmeier SL; Lager KM; Grubman MJ; Brough DE; Ettyreddy D; Sacco RE; Gauger PC; Loving CL; Vorwald AC; Kehrli ME; Lehmkuhl HD
    Viral Immunol; 2009 Jun; 22(3):173-80. PubMed ID: 19435413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dendritic cell-targeted porcine reproductive and respiratory syndrome virus (PRRSV) antigens adjuvanted with polyinosinic-polycytidylic acid (poly (I:C)) induced non-protective immune responses against heterologous type 2 PRRSV challenge in pigs.
    Subramaniam S; Piñeyro P; Derscheid RJ; Madson DM; Magstadt DR; Meng XJ
    Vet Immunol Immunopathol; 2017 Aug; 190():18-25. PubMed ID: 28778318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation of interleukin-10 gene expression in the leukocytes of pigs infected with porcine reproductive and respiratory syndrome virus.
    Suradhat S; Thanawongnuwech R
    J Gen Virol; 2003 Oct; 84(Pt 10):2755-2760. PubMed ID: 13679610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic relationships of antibody response, viremia level, and weight gain in pigs experimentally infected with porcine reproductive and respiratory syndrome virus1.
    Hess AS; Trible BR; Hess MK; Rowland RR; Lunney JK; Plastow GS; Dekkers JCM
    J Anim Sci; 2018 Sep; 96(9):3565-3581. PubMed ID: 29905795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune responses and protection by vaccine and various vaccine adjuvant candidates to virulent porcine reproductive and respiratory syndrome virus.
    Charerntantanakul W; Platt R; Johnson W; Roof M; Vaughn E; Roth JA
    Vet Immunol Immunopathol; 2006 Jan; 109(1-2):99-115. PubMed ID: 16165219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concurrent vaccination of pigs with type 1 and type 2 porcine reproductive and respiratory syndrome virus (PRRSV) protects against type 1 PRRSV but not against type 2 PRRSV on dually challenged pigs.
    Park C; Choi K; Jeong J; Kang I; Park SJ; Chae C
    Res Vet Sci; 2015 Dec; 103():193-200. PubMed ID: 26679817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attempts to enhance cross-protection against porcine reproductive and respiratory syndrome viruses using chimeric viruses containing structural genes from two antigenically distinct strains.
    Sun D; Khatun A; Kim WI; Cooper V; Cho YI; Wang C; Choi EJ; Yoon KJ
    Vaccine; 2016 Aug; 34(36):4335-42. PubMed ID: 27406935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural infection with torque teno sus virus 1 (TTSuV1) suppresses the immune response to porcine reproductive and respiratory syndrome virus (PRRSV) vaccination.
    Zhang Z; Wang Y; Fan H; Lu C
    Arch Virol; 2012 May; 157(5):927-33. PubMed ID: 22327391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of factors associated with virus level in tonsils of pigs experimentally infected with porcine reproductive and respiratory syndrome virus.
    Hess AS; Lunney JK; Abrams S; Choi I; Trible BR; Hess MK; Rowland RRR; Plastow GS; Dekkers JCM
    J Anim Sci; 2019 Feb; 97(2):536-547. PubMed ID: 30496411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of simultaneous vaccination with two modified live virus vaccines against porcine reproductive and respiratory syndrome virus types 1 and 2 in pigs.
    Kristensen CS; Kvisgaard LK; Pawlowski M; Holmgaard Carlsen S; Hjulsager CK; Heegaard PMH; Bøtner A; Stadejek T; Haugegaard S; Larsen LE
    Vaccine; 2018 Jan; 36(2):227-236. PubMed ID: 29191738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of porcine reproductive and respiratory syndrome virus (PRRSV)-specific regulatory T lymphocytes (Treg) in the lungs and tracheobronchial lymph nodes of PRRSV-infected pigs.
    Nedumpun T; Sirisereewan C; Thanmuan C; Techapongtada P; Puntarotairung R; Naraprasertkul S; Thanawongnuwech R; Suradhat S
    Vet Microbiol; 2018 Mar; 216():13-19. PubMed ID: 29519507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Chinese highly pathogenic porcine reproductive and respiratory syndrome virus infection suppresses Th17 cells response in vivo.
    Zhang L; Zhou L; Ge X; Guo X; Han J; Yang H
    Vet Microbiol; 2016 Jun; 189():75-85. PubMed ID: 27259830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the efficacy of a new modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine (Fostera PRRS) against heterologous PRRSV challenge.
    Park C; Seo HW; Han K; Kang I; Chae C
    Vet Microbiol; 2014 Aug; 172(3-4):432-42. PubMed ID: 24970363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.